Rogaine and Melatonin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Rogaine (minoxidil) and Melatonin (melatonin). Common drug interactions include overdose among females and basal cell carcinoma among males.

The phase IV clinical study analyzes what interactions people have when they take Rogaine and Melatonin. It is created by eHealthMe based on reports of 59 people who take the same drugs from the FDA, and is updated regularly.

What is Rogaine?

Rogaine has active ingredients of minoxidil. It is often used in hair loss. eHealthMe is studying from 34,083 Rogaine users. Check the latest studies of Rogaine.

What is Melatonin?

Melatonin has active ingredients of melatonin. It is often used in insomnia. eHealthMe is studying from 56,212 Melatonin users. Check the latest studies of Melatonin.



On Jul, 30, 2026

59 people who take Rogaine and Melatonin together, and have interactions are studied.

Rogaine and Melatonin drug interactions.

What are the common drug interactions of Rogaine and Melatonin, by gender? *:

female:

  1. Overdose
  2. Hair colour changes
  3. Erythema (redness of the skin)
  4. Pruritus (severe itching of the skin)
  5. Hair disorder
  6. Therapeutic response unexpected
  7. Drug effect decreased
  8. Pain of skin
  9. Dizziness
  10. Pain

male:

  1. Basal cell carcinoma (a skin cancer, it rarely metastasizes or kills)
  2. Bladder cancer
  3. Loss of consciousness
  4. Malignant melanoma stage i (cancer has formed; the tumour is not more than 1 millimetre thick, with no ulceration)
  5. Sinus bradycardia (an unusually slow heartbeat due to heart disease)
  6. Malignant melanoma (skin cancer rises from melancytes)
  7. Plasma cell myeloma (cancer that begins in plasma cells)
  8. Squamous cell carcinoma (a cancer of a kind of epithelial cell)
  9. Ureteric cancer
  10. Overdose

What are the common drug interactions of Rogaine and Melatonin, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Erythema (redness of the skin)
  2. Lip dry
  3. Lip exfoliation
  4. Lymphadenopathy (disease or enlargement of lymph nodes)
  5. Pruritus (severe itching of the skin)
  6. Rash generalised (rash on most of body parts)
  7. Scab (a hard coating on the skin formed during the wound healing)
  8. Skin burning sensation
  9. Skin irritation

40-49:

  1. Fatigue (feeling of tiredness)
  2. Fibromyalgia (a long-term condition which causes pain all over the body)
  3. Visual impairment
  4. Overdose
  5. Abnormal dreams
  6. Dizziness
  7. Dry eye (lack of adequate tears)
  8. Gastrointestinal disorder (functional problems of gastrointestinal tract)
  9. Heart rate irregular
  10. Hot flush (sudden feelings of heat)

50-59:

  1. Hair colour changes
  2. Overdose
  3. Therapeutic response unexpected
  4. Basal cell carcinoma (a skin cancer, it rarely metastasizes or kills)
  5. Bladder cancer
  6. Plasma cell myeloma (cancer that begins in plasma cells)
  7. Squamous cell carcinoma (a cancer of a kind of epithelial cell)
  8. Ureteric cancer
  9. Lymphoma (cancer that begins in immune system cells)
  10. Drug ineffective

60+:

  1. Overdose
  2. Hair disorder
  3. Hepatic enzyme decreased
  4. Protein total increased
  5. Seborrhoeic dermatitis (a common, inflammatory skin condition that causes flaky, white to yellowish scales to form on oily areas such as the scalp)
  6. Acne (skin problems that cause pimples)
  7. Application site irritation
  8. Application site pruritus (application site severe itching of the skin)
  9. Burning sensation
  10. Depression

What are the existing conditions these people have? *

  1. Sleep Disorder: 29 people, 49.15%
  2. High Blood Cholesterol: 11 people, 18.64%
  3. High Blood Pressure: 9 people, 15.25%
  4. Cardiac Disorder: 8 people, 13.56%
  5. Stress And Anxiety: 8 people, 13.56%
  6. Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 7 people, 11.86%
  7. Dry Eyes (lack of adequate tears): 6 people, 10.17%
  8. Hair Growth Abnormal: 6 people, 10.17%
  9. Multiple Allergies (allergy to multiple agents): 5 people, 8.47%
  10. Depression: 5 people, 8.47%

* Approximation only. Some reports may have incomplete information.

Do you take Rogaine and Melatonin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Rogaine and Melatonin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Rogaine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Melatonin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Rogaine and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Melatonin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on minoxidil and melatonin (the active ingredients of Rogaine and Melatonin, respectively), and Rogaine and Melatonin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: